US M&A financial advisers: completed deals
H1 2025 · US M&A completed · 6 deals · US$651m disclosed
Columns
Every deal that counts towards this table, with the firms credited on it. Tick deals to leave them out of the ranking or to rank only those deals; the page then says the ranking is a custom view.
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2025 | StoreLocal | principals of the StoreLocal Group | entities managed by Blackrock | Acquisition | 284.9 | Completed | REITs | Highbury Partnership (sell-side) | entities managed by Blackrock acquisition of StoreLocal | |
| May 2025 | Grover Charitable Gaming | – | Light & Wonder | Acquisition | – | Completed | Hospitality & Leisure | Jarden (buy-side) | Light & Wonder acquisition of Grover Charitable Gaming | |
| May 2025 | Prime100 | – | Colgate-Palmolive | Asset sale | 321.3 | Completed | Food & Beverage+1 | Houlihan Lokey (sell-side) | Colgate-Palmolive acquisition of Prime100 | |
| Mar 2025 | Five Good Friends | – | TPG Capital | Acquisition | – | Completed | Consumer Brands | Record Point (sell-side) | TPG Capital acquisition of Five Good Friends | |
| Feb 2025 | MedTech Global | – | Banyan Software | Acquisition | – | Completed | Software+1 | Allier Capital (sell-side) | Banyan Software acquisition of MedTech Global | |
| Jan 2025 | ImaginAb therapeutic candidates, biologics technology platform and research facility | ImaginAb | Telix Pharmaceuticals | Asset sale | 45.0 | Completed | Healthcare+1 | Jefferies (sell-side)Stifel (sell-side) | Telix Pharmaceuticals acquisition of ImaginAb therapeutic candidates, biologics technology platform and research facility |
3 deals have no disclosed value. Methodology